| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| PTEN Phosphohydrolase | 17 | 2022 | 108 | 3.830 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 27 | 2017 | 49 | 3.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 24 | 2019 | 756 | 3.040 |
Why?
|
| Trans-Activators | 27 | 2017 | 237 | 2.980 |
Why?
|
| Stromal Cells | 13 | 2022 | 113 | 2.740 |
Why?
|
| Transcription Factors | 39 | 2019 | 753 | 2.720 |
Why?
|
| Proto-Oncogene Proteins | 33 | 2009 | 411 | 2.680 |
Why?
|
| Breast Neoplasms | 22 | 2022 | 1536 | 2.620 |
Why?
|
| Signal Transduction | 50 | 2022 | 2689 | 2.500 |
Why?
|
| Tumor Microenvironment | 13 | 2022 | 213 | 2.430 |
Why?
|
| DNA-Binding Proteins | 32 | 2012 | 700 | 2.260 |
Why?
|
| Osteoclasts | 18 | 2016 | 132 | 2.210 |
Why?
|
| Pancreatic Neoplasms | 8 | 2023 | 332 | 2.210 |
Why?
|
| Mice | 113 | 2023 | 8474 | 2.170 |
Why?
|
| Cell Transformation, Neoplastic | 11 | 2023 | 235 | 1.890 |
Why?
|
| Carcinoma, Pancreatic Ductal | 5 | 2022 | 46 | 1.780 |
Why?
|
| Cancer-Associated Fibroblasts | 3 | 2022 | 9 | 1.780 |
Why?
|
| Animals | 130 | 2023 | 20881 | 1.690 |
Why?
|
| Fibroblasts | 21 | 2023 | 902 | 1.600 |
Why?
|
| Mammary Neoplasms, Animal | 5 | 2018 | 44 | 1.600 |
Why?
|
| Repressor Proteins | 16 | 2019 | 183 | 1.580 |
Why?
|
| Cell Differentiation | 21 | 2019 | 1034 | 1.540 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 15 | 2016 | 28 | 1.500 |
Why?
|
| Macrophages | 22 | 2018 | 647 | 1.490 |
Why?
|
| Mammary Glands, Animal | 5 | 2018 | 71 | 1.440 |
Why?
|
| Promoter Regions, Genetic | 38 | 2019 | 615 | 1.430 |
Why?
|
| MicroRNAs | 7 | 2020 | 447 | 1.300 |
Why?
|
| Mammary Neoplasms, Experimental | 8 | 2018 | 114 | 1.250 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 6 | 2020 | 65 | 1.180 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2022 | 231 | 1.170 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2017 | 328 | 1.140 |
Why?
|
| Neoplasms | 6 | 2023 | 1667 | 1.110 |
Why?
|
| Oncogenes | 5 | 2022 | 71 | 1.100 |
Why?
|
| Gene Expression Regulation | 24 | 2019 | 1293 | 1.080 |
Why?
|
| Carcinogenesis | 7 | 2023 | 124 | 1.060 |
Why?
|
| Neovascularization, Physiologic | 6 | 2019 | 164 | 1.000 |
Why?
|
| Cell Proliferation | 20 | 2021 | 1174 | 0.980 |
Why?
|
| Mammary Glands, Human | 4 | 2021 | 33 | 0.960 |
Why?
|
| Carrier Proteins | 7 | 2018 | 597 | 0.950 |
Why?
|
| Epithelial Cells | 8 | 2018 | 431 | 0.950 |
Why?
|
| Macrophage Colony-Stimulating Factor | 12 | 2018 | 26 | 0.950 |
Why?
|
| Genes, ras | 12 | 2015 | 46 | 0.790 |
Why?
|
| Proto-Oncogene Proteins c-ets | 7 | 2017 | 79 | 0.780 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 9 | 2008 | 12 | 0.780 |
Why?
|
| Carcinoma | 5 | 2015 | 215 | 0.760 |
Why?
|
| Cell Communication | 5 | 2011 | 116 | 0.750 |
Why?
|
| Homeodomain Proteins | 3 | 2019 | 157 | 0.740 |
Why?
|
| Endothelial Cells | 6 | 2020 | 384 | 0.740 |
Why?
|
| Acid Phosphatase | 9 | 2013 | 36 | 0.740 |
Why?
|
| Cell Line, Tumor | 22 | 2022 | 1851 | 0.730 |
Why?
|
| Transcription, Genetic | 15 | 2013 | 562 | 0.710 |
Why?
|
| Mitogen-Activated Protein Kinases | 8 | 2006 | 250 | 0.710 |
Why?
|
| Disease Models, Animal | 12 | 2020 | 2550 | 0.710 |
Why?
|
| Metaplasia | 2 | 2016 | 27 | 0.700 |
Why?
|
| RANK Ligand | 9 | 2016 | 73 | 0.690 |
Why?
|
| Humans | 94 | 2023 | 68618 | 0.690 |
Why?
|
| Oncogene Protein p21(ras) | 3 | 2014 | 7 | 0.680 |
Why?
|
| Mice, Knockout | 20 | 2021 | 1692 | 0.670 |
Why?
|
| Gene Expression Profiling | 7 | 2018 | 498 | 0.670 |
Why?
|
| Isoenzymes | 10 | 2013 | 308 | 0.670 |
Why?
|
| Myeloid Progenitor Cells | 3 | 2010 | 9 | 0.660 |
Why?
|
| NF-kappa B | 8 | 2019 | 432 | 0.650 |
Why?
|
| Transcriptional Activation | 10 | 2008 | 226 | 0.640 |
Why?
|
| Radiation Tolerance | 1 | 2018 | 30 | 0.630 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2017 | 5 | 0.600 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2017 | 17 | 0.590 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 6 | 2022 | 78 | 0.580 |
Why?
|
| Jagged-1 Protein | 1 | 2016 | 3 | 0.570 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2016 | 48 | 0.560 |
Why?
|
| Acinar Cells | 1 | 2016 | 8 | 0.560 |
Why?
|
| Transfection | 23 | 2010 | 782 | 0.560 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 5 | 2016 | 134 | 0.560 |
Why?
|
| Smoothened Receptor | 1 | 2016 | 10 | 0.560 |
Why?
|
| Mice, Inbred C57BL | 20 | 2019 | 2791 | 0.560 |
Why?
|
| Mice, Transgenic | 21 | 2018 | 1033 | 0.560 |
Why?
|
| Cell Line | 23 | 2021 | 1752 | 0.550 |
Why?
|
| Proto-Oncogene Proteins c-akt | 11 | 2021 | 331 | 0.550 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2019 | 135 | 0.540 |
Why?
|
| Pancreatic Ducts | 1 | 2016 | 76 | 0.540 |
Why?
|
| Chemokines | 2 | 2016 | 119 | 0.540 |
Why?
|
| Phosphorylation | 22 | 2019 | 1200 | 0.530 |
Why?
|
| Embryo, Mammalian | 5 | 2015 | 176 | 0.510 |
Why?
|
| Pancreas | 3 | 2023 | 225 | 0.510 |
Why?
|
| Molecular Sequence Data | 28 | 2010 | 1447 | 0.500 |
Why?
|
| Stem Cells | 1 | 2016 | 248 | 0.490 |
Why?
|
| Female | 41 | 2022 | 38074 | 0.490 |
Why?
|
| Cells, Cultured | 19 | 2019 | 2673 | 0.490 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2009 | 150 | 0.490 |
Why?
|
| Nuclear Proteins | 8 | 2017 | 271 | 0.480 |
Why?
|
| Base Sequence | 27 | 2010 | 1015 | 0.480 |
Why?
|
| Cell Movement | 8 | 2021 | 630 | 0.480 |
Why?
|
| Gene Deletion | 6 | 2016 | 235 | 0.470 |
Why?
|
| 3T3 Cells | 14 | 2016 | 124 | 0.460 |
Why?
|
| I-kappa B Kinase | 3 | 2013 | 40 | 0.460 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 95 | 0.460 |
Why?
|
| Osteoprotegerin | 2 | 2010 | 11 | 0.450 |
Why?
|
| Gene Expression | 13 | 2016 | 770 | 0.450 |
Why?
|
| Tumor Cells, Cultured | 14 | 2016 | 852 | 0.450 |
Why?
|
| NFATC Transcription Factors | 3 | 2008 | 40 | 0.450 |
Why?
|
| Cell Survival | 11 | 2021 | 901 | 0.440 |
Why?
|
| Membrane Glycoproteins | 4 | 2004 | 370 | 0.420 |
Why?
|
| ras Proteins | 4 | 2017 | 102 | 0.410 |
Why?
|
| Cell Cycle Proteins | 3 | 2019 | 230 | 0.400 |
Why?
|
| Cell Cycle | 4 | 2019 | 312 | 0.390 |
Why?
|
| MAP Kinase Signaling System | 6 | 2016 | 247 | 0.390 |
Why?
|
| Protein Kinase C beta | 2 | 2021 | 19 | 0.390 |
Why?
|
| E2F3 Transcription Factor | 3 | 2019 | 46 | 0.380 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 9 | 2013 | 22 | 0.380 |
Why?
|
| Genome | 2 | 2017 | 54 | 0.370 |
Why?
|
| Cachexia | 2 | 2023 | 54 | 0.370 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2009 | 147 | 0.370 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 5 | 2003 | 107 | 0.370 |
Why?
|
| Brain Neoplasms | 5 | 2018 | 371 | 0.350 |
Why?
|
| Placenta | 2 | 2008 | 101 | 0.350 |
Why?
|
| Neoplasm Metastasis | 7 | 2021 | 306 | 0.350 |
Why?
|
| Extracellular Matrix | 6 | 2021 | 493 | 0.340 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 8 | 2017 | 320 | 0.340 |
Why?
|
| Embryonic Development | 2 | 2010 | 100 | 0.340 |
Why?
|
| Collagen | 5 | 2021 | 636 | 0.340 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2010 | 194 | 0.330 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 5 | 2000 | 43 | 0.330 |
Why?
|
| Nerve Tissue Proteins | 2 | 2009 | 290 | 0.320 |
Why?
|
| Microscopy | 1 | 2008 | 64 | 0.310 |
Why?
|
| Pattern Recognition, Automated | 1 | 2008 | 70 | 0.310 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2021 | 331 | 0.310 |
Why?
|
| Cathepsins | 5 | 2009 | 37 | 0.300 |
Why?
|
| Membrane Proteins | 3 | 2018 | 617 | 0.300 |
Why?
|
| Genes, BRCA1 | 3 | 2015 | 47 | 0.300 |
Why?
|
| Disease Progression | 6 | 2019 | 1038 | 0.300 |
Why?
|
| Mutation | 10 | 2021 | 1213 | 0.300 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2004 | 56 | 0.300 |
Why?
|
| Antineoplastic Agents | 5 | 2021 | 1070 | 0.290 |
Why?
|
| Inflammation | 4 | 2019 | 1030 | 0.280 |
Why?
|
| Oncolytic Viruses | 2 | 2018 | 17 | 0.280 |
Why?
|
| Phenotype | 7 | 2017 | 947 | 0.280 |
Why?
|
| 14-3-3 Proteins | 1 | 2006 | 12 | 0.280 |
Why?
|
| Cathepsin K | 6 | 2013 | 16 | 0.280 |
Why?
|
| RNA, Messenger | 14 | 2013 | 1664 | 0.280 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 237 | 0.270 |
Why?
|
| Macrophages, Peritoneal | 5 | 2006 | 67 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2014 | 90 | 0.260 |
Why?
|
| ErbB Receptors | 2 | 2018 | 239 | 0.260 |
Why?
|
| Neoplasm Invasiveness | 4 | 2018 | 369 | 0.260 |
Why?
|
| Dietary Fats | 3 | 2021 | 103 | 0.260 |
Why?
|
| Glioblastoma | 3 | 2013 | 219 | 0.260 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 468 | 0.250 |
Why?
|
| Blotting, Western | 5 | 2011 | 954 | 0.250 |
Why?
|
| Lung Neoplasms | 5 | 2017 | 1173 | 0.250 |
Why?
|
| DNA Helicases | 3 | 2013 | 64 | 0.250 |
Why?
|
| Genomics | 1 | 2006 | 168 | 0.240 |
Why?
|
| Glioma | 2 | 2018 | 140 | 0.240 |
Why?
|
| Enhancer Elements, Genetic | 7 | 1998 | 63 | 0.240 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 2019 | 195 | 0.230 |
Why?
|
| Monocytes | 5 | 2018 | 210 | 0.230 |
Why?
|
| Apoptosis | 2 | 2009 | 1641 | 0.230 |
Why?
|
| Proto-Oncogenes | 2 | 1994 | 37 | 0.230 |
Why?
|
| Enzyme Activation | 10 | 2021 | 791 | 0.230 |
Why?
|
| Models, Biological | 4 | 2018 | 981 | 0.230 |
Why?
|
| Mutation, Missense | 2 | 2015 | 112 | 0.220 |
Why?
|
| COS Cells | 4 | 2013 | 155 | 0.220 |
Why?
|
| Neovascularization, Pathologic | 3 | 2014 | 183 | 0.220 |
Why?
|
| Transgenes | 3 | 2018 | 92 | 0.210 |
Why?
|
| Down-Regulation | 6 | 2017 | 447 | 0.210 |
Why?
|
| Protein Binding | 7 | 2021 | 1027 | 0.210 |
Why?
|
| Connective Tissue | 1 | 2022 | 61 | 0.210 |
Why?
|
| Algorithms | 1 | 2008 | 1196 | 0.210 |
Why?
|
| Antigens, CD34 | 2 | 2019 | 75 | 0.210 |
Why?
|
| Glycogen | 1 | 2021 | 27 | 0.200 |
Why?
|
| Gene Silencing | 4 | 2010 | 137 | 0.200 |
Why?
|
| Prostatic Neoplasms | 3 | 2019 | 778 | 0.200 |
Why?
|
| Immunohistochemistry | 5 | 2016 | 1174 | 0.200 |
Why?
|
| ral GTP-Binding Proteins | 1 | 2021 | 3 | 0.200 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2013 | 64 | 0.190 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2021 | 10 | 0.190 |
Why?
|
| Microphthalmos | 3 | 2016 | 9 | 0.190 |
Why?
|
| Genes, Reporter | 4 | 2008 | 191 | 0.190 |
Why?
|
| Receptors, Lipoprotein | 1 | 2000 | 11 | 0.190 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2021 | 41 | 0.190 |
Why?
|
| Biomarkers, Tumor | 3 | 2018 | 508 | 0.190 |
Why?
|
| Arginine | 1 | 2021 | 102 | 0.180 |
Why?
|
| Neoplastic Stem Cells | 2 | 2013 | 84 | 0.180 |
Why?
|
| DNA Methylation | 4 | 2010 | 193 | 0.180 |
Why?
|
| Leukemia, T-Cell | 1 | 2020 | 21 | 0.180 |
Why?
|
| Pancreatic Stellate Cells | 2 | 2017 | 3 | 0.180 |
Why?
|
| STAT Transcription Factors | 2 | 2017 | 13 | 0.180 |
Why?
|
| Janus Kinases | 2 | 2017 | 11 | 0.180 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 22 | 0.180 |
Why?
|
| Gene Knockout Techniques | 3 | 2018 | 61 | 0.180 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 81 | 0.180 |
Why?
|
| Mice, Mutant Strains | 4 | 2009 | 166 | 0.180 |
Why?
|
| Recombinant Proteins | 7 | 2013 | 742 | 0.180 |
Why?
|
| Osteonectin | 1 | 2021 | 69 | 0.180 |
Why?
|
| B7-H1 Antigen | 2 | 2018 | 30 | 0.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 266 | 0.180 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 87 | 0.170 |
Why?
|
| E2F4 Transcription Factor | 1 | 2019 | 9 | 0.170 |
Why?
|
| Nanofibers | 1 | 2019 | 21 | 0.170 |
Why?
|
| Luciferases | 6 | 2015 | 105 | 0.170 |
Why?
|
| Prognosis | 7 | 2023 | 2093 | 0.170 |
Why?
|
| Receptors, Immunologic | 2 | 2015 | 72 | 0.170 |
Why?
|
| Muscle, Skeletal | 4 | 2023 | 396 | 0.170 |
Why?
|
| Liver | 2 | 2021 | 1118 | 0.160 |
Why?
|
| Hepatocytes | 1 | 2020 | 205 | 0.160 |
Why?
|
| Herpesviridae | 1 | 2018 | 11 | 0.160 |
Why?
|
| Morphogenesis | 2 | 2017 | 159 | 0.160 |
Why?
|
| GTPase-Activating Proteins | 3 | 2013 | 21 | 0.160 |
Why?
|
| Chemokine CXCL12 | 2 | 2018 | 51 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 710 | 0.160 |
Why?
|
| Male | 18 | 2020 | 37321 | 0.160 |
Why?
|
| Genes, myc | 3 | 2008 | 26 | 0.160 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2018 | 24 | 0.160 |
Why?
|
| Cell Nucleus | 4 | 2015 | 305 | 0.160 |
Why?
|
| Thyroid Hormones | 1 | 2018 | 31 | 0.160 |
Why?
|
| Osteopetrosis | 3 | 2009 | 8 | 0.160 |
Why?
|
| Mammary Tumor Virus, Mouse | 3 | 1988 | 8 | 0.160 |
Why?
|
| Gamma Rays | 1 | 2018 | 64 | 0.160 |
Why?
|
| Blood Glucose | 1 | 2021 | 631 | 0.160 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2018 | 8 | 0.160 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2018 | 9 | 0.160 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 17 | 0.150 |
Why?
|
| Genomic Instability | 1 | 2018 | 41 | 0.150 |
Why?
|
| BRCA1 Protein | 1 | 2018 | 30 | 0.150 |
Why?
|
| Hedgehog Proteins | 1 | 2018 | 38 | 0.150 |
Why?
|
| RNA, Small Nucleolar | 1 | 2017 | 2 | 0.150 |
Why?
|
| DNA Repair | 1 | 2018 | 127 | 0.150 |
Why?
|
| Luminescent Proteins | 3 | 2009 | 57 | 0.150 |
Why?
|
| Genes, fms | 5 | 1996 | 5 | 0.150 |
Why?
|
| Interleukin-18 | 1 | 2017 | 16 | 0.150 |
Why?
|
| Bone Marrow Cells | 3 | 2009 | 217 | 0.150 |
Why?
|
| Urokinase-Type Plasminogen Activator | 4 | 2000 | 26 | 0.150 |
Why?
|
| Ceruletide | 1 | 2017 | 8 | 0.150 |
Why?
|
| Osteosarcoma | 1 | 2017 | 35 | 0.150 |
Why?
|
| RNA Interference | 3 | 2017 | 266 | 0.150 |
Why?
|
| Interleukins | 1 | 2017 | 79 | 0.140 |
Why?
|
| Wound Healing | 1 | 2019 | 260 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2015 | 536 | 0.140 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 195 | 0.140 |
Why?
|
| Receptor, Notch3 | 1 | 2016 | 2 | 0.140 |
Why?
|
| S100 Proteins | 2 | 2015 | 42 | 0.140 |
Why?
|
| Cyclin D1 | 2 | 2007 | 37 | 0.140 |
Why?
|
| Epidermal Growth Factor | 4 | 2009 | 95 | 0.140 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2016 | 5 | 0.140 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 100 | 0.140 |
Why?
|
| Cell Membrane | 3 | 2021 | 525 | 0.140 |
Why?
|
| Endothelium, Vascular | 3 | 2009 | 371 | 0.140 |
Why?
|
| Up-Regulation | 4 | 2017 | 682 | 0.140 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2016 | 30 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2017 | 228 | 0.140 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2016 | 25 | 0.140 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 94 | 0.140 |
Why?
|
| Receptor, Notch1 | 2 | 2020 | 11 | 0.140 |
Why?
|
| Receptors, Cell Surface | 4 | 2004 | 248 | 0.140 |
Why?
|
| Peptide Fragments | 2 | 2013 | 483 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2015 | 376 | 0.140 |
Why?
|
| Ovarian Neoplasms | 1 | 1998 | 267 | 0.140 |
Why?
|
| Transcriptome | 4 | 2019 | 164 | 0.130 |
Why?
|
| Skin | 1 | 2019 | 451 | 0.130 |
Why?
|
| Enzyme Inhibitors | 4 | 2021 | 659 | 0.130 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2016 | 19 | 0.130 |
Why?
|
| STAT5 Transcription Factor | 1 | 2015 | 18 | 0.130 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2015 | 11 | 0.130 |
Why?
|
| Actins | 3 | 2016 | 249 | 0.130 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 40 | 0.130 |
Why?
|
| T-Lymphocytes | 2 | 2018 | 597 | 0.130 |
Why?
|
| Hyaluronic Acid | 1 | 2017 | 206 | 0.130 |
Why?
|
| Hemolysin Proteins | 1 | 2015 | 9 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 322 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2015 | 786 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 4 | 2018 | 200 | 0.130 |
Why?
|
| Protein Engineering | 1 | 2015 | 35 | 0.130 |
Why?
|
| Pancreatitis, Chronic | 1 | 2017 | 168 | 0.130 |
Why?
|
| Endotoxins | 1 | 2015 | 76 | 0.130 |
Why?
|
| Lung | 4 | 2015 | 849 | 0.130 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1996 | 123 | 0.130 |
Why?
|
| Precipitin Tests | 3 | 2003 | 88 | 0.120 |
Why?
|
| Nestin | 1 | 2014 | 6 | 0.120 |
Why?
|
| Embryo Loss | 3 | 2010 | 17 | 0.120 |
Why?
|
| Angiogenic Proteins | 1 | 2014 | 5 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2016 | 330 | 0.120 |
Why?
|
| Proteins | 4 | 2009 | 474 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2019 | 626 | 0.120 |
Why?
|
| RNA, Small Interfering | 3 | 2021 | 434 | 0.120 |
Why?
|
| Gene Knock-In Techniques | 2 | 2015 | 35 | 0.120 |
Why?
|
| Glucocorticoids | 2 | 1988 | 222 | 0.120 |
Why?
|
| Protein Isoforms | 3 | 2013 | 246 | 0.120 |
Why?
|
| Forkhead Transcription Factors | 2 | 2015 | 94 | 0.110 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2013 | 2 | 0.110 |
Why?
|
| Myosin Light Chains | 1 | 2013 | 18 | 0.110 |
Why?
|
| Cell Compartmentation | 1 | 2013 | 41 | 0.110 |
Why?
|
| Polycomb-Group Proteins | 1 | 2013 | 2 | 0.110 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2013 | 4 | 0.110 |
Why?
|
| Phosphatidylserines | 1 | 2013 | 22 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 56 | 0.110 |
Why?
|
| Receptors, IgG | 2 | 2004 | 94 | 0.110 |
Why?
|
| Myocardium | 1 | 2019 | 1204 | 0.110 |
Why?
|
| Exosomes | 1 | 2013 | 44 | 0.110 |
Why?
|
| Saposins | 1 | 2013 | 24 | 0.110 |
Why?
|
| Vasoconstriction | 1 | 2013 | 81 | 0.110 |
Why?
|
| Adaptive Immunity | 1 | 2013 | 37 | 0.110 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 245 | 0.110 |
Why?
|
| HEK293 Cells | 3 | 2021 | 326 | 0.110 |
Why?
|
| Snail Family Transcription Factors | 1 | 2012 | 31 | 0.110 |
Why?
|
| Plasmids | 6 | 1998 | 258 | 0.110 |
Why?
|
| Cell Lineage | 3 | 2017 | 146 | 0.110 |
Why?
|
| Oncogene Protein gp140(v-fms) | 1 | 1992 | 1 | 0.110 |
Why?
|
| Chromones | 2 | 2004 | 33 | 0.110 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2015 | 199 | 0.100 |
Why?
|
| Receptor, ErbB-2 | 2 | 2018 | 129 | 0.100 |
Why?
|
| Amino Acid Sequence | 6 | 2002 | 1083 | 0.100 |
Why?
|
| Morpholines | 2 | 2004 | 79 | 0.100 |
Why?
|
| Helix-Loop-Helix Motifs | 3 | 2002 | 9 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2021 | 304 | 0.100 |
Why?
|
| Thyroid Neoplasms | 1 | 2013 | 68 | 0.100 |
Why?
|
| Mesoderm | 3 | 2023 | 231 | 0.100 |
Why?
|
| Mice, Nude | 3 | 2021 | 294 | 0.100 |
Why?
|
| Neoplasm Proteins | 2 | 2013 | 307 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 71 | 0.100 |
Why?
|
| Dendritic Cells | 3 | 2018 | 201 | 0.100 |
Why?
|
| Blotting, Northern | 2 | 2003 | 189 | 0.100 |
Why?
|
| Organ Specificity | 3 | 2017 | 167 | 0.100 |
Why?
|
| Binding Sites | 6 | 2008 | 631 | 0.100 |
Why?
|
| Alleles | 2 | 2010 | 386 | 0.100 |
Why?
|
| Sequence Alignment | 4 | 2000 | 165 | 0.100 |
Why?
|
| Macrophages, Alveolar | 1 | 2011 | 34 | 0.100 |
Why?
|
| Lipopolysaccharides | 4 | 2011 | 455 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2009 | 223 | 0.100 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1991 | 9 | 0.100 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2013 | 317 | 0.100 |
Why?
|
| NIH 3T3 Cells | 2 | 2010 | 65 | 0.100 |
Why?
|
| Macrophage Activation | 1 | 2011 | 75 | 0.100 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1991 | 50 | 0.090 |
Why?
|
| Zinc Fingers | 2 | 2009 | 17 | 0.090 |
Why?
|
| Chimera | 2 | 2009 | 33 | 0.090 |
Why?
|
| Genes, Regulator | 2 | 2003 | 17 | 0.090 |
Why?
|
| S Phase | 1 | 2010 | 38 | 0.090 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 3 | 2009 | 17 | 0.090 |
Why?
|
| E2F2 Transcription Factor | 1 | 2010 | 29 | 0.090 |
Why?
|
| E2F1 Transcription Factor | 1 | 2010 | 44 | 0.090 |
Why?
|
| Phagocytosis | 3 | 2006 | 65 | 0.090 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2010 | 20 | 0.090 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2009 | 114 | 0.090 |
Why?
|
| Transforming Growth Factors | 1 | 1990 | 12 | 0.090 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2010 | 33 | 0.090 |
Why?
|
| ras GTPase-Activating Proteins | 3 | 2017 | 6 | 0.090 |
Why?
|
| Homeostasis | 2 | 2023 | 291 | 0.090 |
Why?
|
| Paxillin | 1 | 2009 | 3 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2015 | 175 | 0.090 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2009 | 27 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2013 | 254 | 0.090 |
Why?
|
| Cell Adhesion | 4 | 2015 | 324 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2010 | 48 | 0.090 |
Why?
|
| Neoplasm Transplantation | 3 | 2019 | 160 | 0.090 |
Why?
|
| Models, Immunological | 1 | 2009 | 25 | 0.090 |
Why?
|
| Kinetics | 3 | 2018 | 1047 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2018 | 332 | 0.090 |
Why?
|
| Lymphocyte Subsets | 1 | 2009 | 16 | 0.090 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2009 | 22 | 0.090 |
Why?
|
| Pulmonary Fibrosis | 1 | 2011 | 157 | 0.080 |
Why?
|
| Embryo Transfer | 1 | 2009 | 18 | 0.080 |
Why?
|
| Fetal Death | 1 | 2009 | 49 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 4 | 2012 | 492 | 0.080 |
Why?
|
| Cystatin M | 1 | 2008 | 1 | 0.080 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2009 | 13 | 0.080 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2009 | 17 | 0.080 |
Why?
|
| Homozygote | 1 | 2009 | 119 | 0.080 |
Why?
|
| Edema | 1 | 2009 | 66 | 0.080 |
Why?
|
| Cherubism | 1 | 2008 | 2 | 0.080 |
Why?
|
| Cyclic AMP | 2 | 2003 | 223 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-jun | 3 | 2016 | 71 | 0.080 |
Why?
|
| Endosomes | 1 | 2009 | 45 | 0.080 |
Why?
|
| Genes, Lethal | 1 | 2008 | 16 | 0.080 |
Why?
|
| Fetal Diseases | 1 | 2009 | 64 | 0.080 |
Why?
|
| Pregnancy | 4 | 2008 | 2334 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2009 | 102 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 1 | 2009 | 40 | 0.080 |
Why?
|
| Pregnancy, Animal | 1 | 2008 | 27 | 0.080 |
Why?
|
| Threonine | 2 | 2000 | 47 | 0.080 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2008 | 30 | 0.080 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2008 | 5 | 0.080 |
Why?
|
| Air Pollution | 1 | 2009 | 54 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2010 | 215 | 0.080 |
Why?
|
| Guanosine Triphosphate | 3 | 1998 | 65 | 0.080 |
Why?
|
| Models, Animal | 1 | 2009 | 252 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2009 | 312 | 0.080 |
Why?
|
| Genes, APC | 1 | 2008 | 15 | 0.080 |
Why?
|
| Integrin beta3 | 1 | 2008 | 35 | 0.080 |
Why?
|
| Obesity | 2 | 2020 | 1076 | 0.080 |
Why?
|
| Intestinal Neoplasms | 1 | 2008 | 30 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2011 | 384 | 0.080 |
Why?
|
| HIV-1 | 2 | 2000 | 177 | 0.080 |
Why?
|
| Trisomy | 1 | 2008 | 47 | 0.080 |
Why?
|
| Osteogenesis | 1 | 2009 | 152 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2008 | 95 | 0.070 |
Why?
|
| Lymphoma, T-Cell | 1 | 2007 | 19 | 0.070 |
Why?
|
| Time Factors | 5 | 2015 | 4655 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2008 | 143 | 0.070 |
Why?
|
| Genes, bcl-1 | 1 | 2007 | 2 | 0.070 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2007 | 6 | 0.070 |
Why?
|
| CpG Islands | 1 | 2007 | 51 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2009 | 216 | 0.070 |
Why?
|
| Cholesterol | 1 | 2009 | 331 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2007 | 27 | 0.070 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2007 | 23 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2009 | 328 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 3 | 2002 | 24 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 384 | 0.070 |
Why?
|
| Chloride Channels | 1 | 2006 | 22 | 0.070 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 2 | 2009 | 62 | 0.070 |
Why?
|
| Methylation | 2 | 2021 | 56 | 0.070 |
Why?
|
| Phosphoserine | 1 | 2006 | 14 | 0.070 |
Why?
|
| Suppression, Genetic | 1 | 2006 | 10 | 0.070 |
Why?
|
| Down Syndrome | 1 | 2008 | 120 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2006 | 62 | 0.070 |
Why?
|
| Capillaries | 1 | 2006 | 105 | 0.070 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2016 | 91 | 0.070 |
Why?
|
| Protein Transport | 1 | 2006 | 280 | 0.060 |
Why?
|
| Enzyme Induction | 2 | 2009 | 119 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2005 | 32 | 0.060 |
Why?
|
| Conserved Sequence | 3 | 2008 | 67 | 0.060 |
Why?
|
| Tamoxifen | 1 | 2005 | 62 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2009 | 489 | 0.060 |
Why?
|
| Interleukin-10 | 1 | 2005 | 144 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2004 | 16 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2004 | 8 | 0.060 |
Why?
|
| Receptors, Colony-Stimulating Factor | 2 | 2011 | 3 | 0.060 |
Why?
|
| Glucose | 2 | 2020 | 307 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1745 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2004 | 5 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2004 | 4 | 0.060 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2004 | 17 | 0.060 |
Why?
|
| Tumor Burden | 2 | 2015 | 132 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 4 | 2011 | 532 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2004 | 33 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2004 | 38 | 0.060 |
Why?
|
| Insulin Resistance | 2 | 2020 | 241 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2004 | 71 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 1753 | 0.060 |
Why?
|
| Foot | 1 | 2004 | 66 | 0.060 |
Why?
|
| Operon | 1 | 1983 | 7 | 0.060 |
Why?
|
| CD13 Antigens | 1 | 2003 | 5 | 0.060 |
Why?
|
| Mutagenesis | 2 | 1996 | 60 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 97 | 0.060 |
Why?
|
| Flavonoids | 1 | 2004 | 109 | 0.060 |
Why?
|
| Co-Repressor Proteins | 1 | 2003 | 8 | 0.060 |
Why?
|
| Femur | 1 | 2004 | 113 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2013 | 7029 | 0.060 |
Why?
|
| Imidazoles | 1 | 2004 | 175 | 0.060 |
Why?
|
| Immunity, Innate | 2 | 2017 | 156 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 1990 | 37 | 0.050 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2003 | 10 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2003 | 144 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2077 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2000 | 140 | 0.050 |
Why?
|
| Retinoblastoma Protein | 1 | 2003 | 75 | 0.050 |
Why?
|
| Protein Stability | 2 | 2015 | 90 | 0.050 |
Why?
|
| Chromatin | 1 | 2003 | 76 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2002 | 22 | 0.050 |
Why?
|
| Radiography | 1 | 2004 | 572 | 0.050 |
Why?
|
| Leucine Zippers | 2 | 1999 | 10 | 0.050 |
Why?
|
| Polycomb Repressive Complex 2 | 2 | 2013 | 13 | 0.050 |
Why?
|
| Histone Deacetylases | 1 | 2003 | 99 | 0.050 |
Why?
|
| Peptide Mapping | 1 | 2002 | 39 | 0.050 |
Why?
|
| Pyridines | 1 | 2004 | 261 | 0.050 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2002 | 23 | 0.050 |
Why?
|
| Glycogen Synthase | 1 | 2021 | 5 | 0.050 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2021 | 8 | 0.050 |
Why?
|
| Gluconeogenesis | 1 | 2021 | 7 | 0.050 |
Why?
|
| Glucokinase | 1 | 2021 | 6 | 0.050 |
Why?
|
| Mice, SCID | 2 | 2019 | 238 | 0.050 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2021 | 20 | 0.050 |
Why?
|
| Cholesterol, Dietary | 1 | 2021 | 22 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2021 | 28 | 0.050 |
Why?
|
| Postprandial Period | 1 | 2021 | 21 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2021 | 57 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 314 | 0.050 |
Why?
|
| DNA Primers | 3 | 1999 | 302 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2021 | 64 | 0.050 |
Why?
|
| Biocatalysis | 1 | 2021 | 23 | 0.050 |
Why?
|
| CD11b Antigen | 2 | 2011 | 47 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2013 | 147 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 214 | 0.050 |
Why?
|
| Filariasis | 1 | 2000 | 2 | 0.050 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2020 | 9 | 0.050 |
Why?
|
| Lipogenesis | 1 | 2020 | 9 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 1 | 2000 | 8 | 0.050 |
Why?
|
| Receptors, Scavenger | 1 | 2000 | 13 | 0.050 |
Why?
|
| Caenorhabditis elegans | 2 | 2017 | 38 | 0.050 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2000 | 18 | 0.050 |
Why?
|
| bcl-X Protein | 1 | 2000 | 36 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2021 | 140 | 0.050 |
Why?
|
| Sequence Deletion | 3 | 2008 | 89 | 0.040 |
Why?
|
| Forelimb | 1 | 2000 | 15 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2020 | 20 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1991 | 138 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 174 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2000 | 124 | 0.040 |
Why?
|
| Twist Transcription Factors | 1 | 2019 | 1 | 0.040 |
Why?
|
| Weight Gain | 1 | 2020 | 135 | 0.040 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2019 | 22 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 201 | 0.040 |
Why?
|
| Bone Resorption | 1 | 2000 | 64 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 1085 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2010 | 159 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 186 | 0.040 |
Why?
|
| Mannose-Binding Lectins | 1 | 1999 | 8 | 0.040 |
Why?
|
| Granulation Tissue | 1 | 2019 | 6 | 0.040 |
Why?
|
| Neutrophil Infiltration | 1 | 2019 | 35 | 0.040 |
Why?
|
| Streptozocin | 1 | 2019 | 34 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 1999 | 74 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2019 | 31 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 1999 | 39 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 70 | 0.040 |
Why?
|
| Dermis | 1 | 2019 | 29 | 0.040 |
Why?
|
| Survival Rate | 2 | 2016 | 1056 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 1999 | 18 | 0.040 |
Why?
|
| Insulin | 1 | 2002 | 619 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2019 | 131 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 138 | 0.040 |
Why?
|
| Phosphothreonine | 1 | 1998 | 5 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 126 | 0.040 |
Why?
|
| Breast Density | 1 | 2018 | 21 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2019 | 220 | 0.040 |
Why?
|
| Pregnancy Proteins | 1 | 1998 | 15 | 0.040 |
Why?
|
| Cloning, Molecular | 3 | 2006 | 357 | 0.040 |
Why?
|
| Prostate | 1 | 2019 | 116 | 0.040 |
Why?
|
| Growth Substances | 2 | 2002 | 77 | 0.040 |
Why?
|
| Receptors, HIV | 1 | 1998 | 5 | 0.040 |
Why?
|
| Cardiomegaly | 1 | 2019 | 213 | 0.040 |
Why?
|
| Immunity | 1 | 2018 | 67 | 0.040 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2018 | 1 | 0.040 |
Why?
|
| Genistein | 1 | 1998 | 26 | 0.040 |
Why?
|
| Interferon Type I | 1 | 1998 | 32 | 0.040 |
Why?
|
| Ectopic Gene Expression | 1 | 2018 | 2 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 1998 | 26 | 0.040 |
Why?
|
| Recombinational DNA Repair | 1 | 2018 | 6 | 0.040 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2018 | 13 | 0.040 |
Why?
|
| Radiation, Ionizing | 1 | 2018 | 37 | 0.040 |
Why?
|
| HIV Long Terminal Repeat | 1 | 1998 | 8 | 0.040 |
Why?
|
| Sp1 Transcription Factor | 1 | 1998 | 21 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 111 | 0.040 |
Why?
|
| Palatine Tonsil | 1 | 2017 | 8 | 0.040 |
Why?
|
| Fibrosis | 1 | 2019 | 371 | 0.040 |
Why?
|
| Cytokines | 2 | 2017 | 866 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 2019 | 223 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2010 | 7277 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2017 | 47 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2017 | 21 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 142 | 0.040 |
Why?
|
| Fetus | 2 | 2011 | 157 | 0.040 |
Why?
|
| Genes, jun | 2 | 1996 | 13 | 0.040 |
Why?
|
| Interleukin-15 | 1 | 2017 | 66 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1999 | 268 | 0.040 |
Why?
|
| L-Selectin | 1 | 2016 | 28 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 1996 | 2 | 0.040 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 1996 | 4 | 0.040 |
Why?
|
| Microglia | 1 | 2018 | 143 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2017 | 99 | 0.040 |
Why?
|
| Oncogene Proteins | 1 | 1996 | 35 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2017 | 122 | 0.030 |
Why?
|
| Okadaic Acid | 1 | 1996 | 22 | 0.030 |
Why?
|
| Ethers, Cyclic | 1 | 1996 | 13 | 0.030 |
Why?
|
| Blood | 1 | 1996 | 40 | 0.030 |
Why?
|
| Species Specificity | 1 | 1997 | 303 | 0.030 |
Why?
|
| Cell Division | 3 | 2006 | 541 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 1996 | 37 | 0.030 |
Why?
|
| Rats | 3 | 2013 | 5300 | 0.030 |
Why?
|
| Heparin | 1 | 1997 | 205 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2008 | 60 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1996 | 204 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2016 | 101 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 714 | 0.030 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2016 | 66 | 0.030 |
Why?
|
| Lens, Crystalline | 1 | 2016 | 39 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2015 | 41 | 0.030 |
Why?
|
| Mitochondria | 1 | 2020 | 643 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2015 | 25 | 0.030 |
Why?
|
| Peyer's Patches | 1 | 2015 | 10 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2016 | 142 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 244 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 800 | 0.030 |
Why?
|
| RAW 264.7 Cells | 1 | 2015 | 42 | 0.030 |
Why?
|
| Crystallization | 1 | 2015 | 57 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2015 | 50 | 0.030 |
Why?
|
| S100 Calcium Binding Protein A7 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 1994 | 8 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2015 | 58 | 0.030 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2015 | 19 | 0.030 |
Why?
|
| Vero Cells | 1 | 2014 | 13 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 1995 | 181 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2010 | 237 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 170 | 0.030 |
Why?
|
| Point Mutation | 2 | 2010 | 97 | 0.030 |
Why?
|
| Oncolytic Virotherapy | 1 | 2014 | 15 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 80 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1995 | 282 | 0.030 |
Why?
|
| DNA | 2 | 1998 | 597 | 0.030 |
Why?
|
| Transduction, Genetic | 2 | 2009 | 81 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1995 | 231 | 0.030 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2013 | 3 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2013 | 45 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2013 | 2358 | 0.030 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2013 | 4 | 0.030 |
Why?
|
| Myosins | 1 | 2013 | 34 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2013 | 60 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 334 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2013 | 27 | 0.030 |
Why?
|
| Biological Transport | 1 | 2013 | 210 | 0.030 |
Why?
|
| Poland | 1 | 2013 | 10 | 0.030 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2013 | 28 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 53 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 45 | 0.030 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2013 | 20 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 91 | 0.030 |
Why?
|
| Ohio | 1 | 2013 | 64 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2013 | 92 | 0.030 |
Why?
|
| Carcinoma, Papillary | 1 | 2013 | 35 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2010 | 282 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 167 | 0.030 |
Why?
|
| Transformation, Genetic | 1 | 1992 | 14 | 0.030 |
Why?
|
| Genes, Viral | 1 | 1993 | 44 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2006 | 122 | 0.030 |
Why?
|
| Thiophenes | 1 | 2013 | 76 | 0.030 |
Why?
|
| Pedigree | 1 | 2013 | 159 | 0.030 |
Why?
|
| Dermatitis | 1 | 2013 | 28 | 0.030 |
Why?
|
| Lac Operon | 1 | 1992 | 54 | 0.030 |
Why?
|
| Endopeptidases | 1 | 1993 | 52 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2013 | 107 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2013 | 99 | 0.030 |
Why?
|
| Family Health | 1 | 2013 | 83 | 0.030 |
Why?
|
| Multigene Family | 1 | 1992 | 93 | 0.030 |
Why?
|
| Aging | 2 | 2009 | 911 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 138 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 1992 | 20 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2013 | 160 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 144 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1993 | 144 | 0.020 |
Why?
|
| Polyomavirus | 1 | 2011 | 4 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 240 | 0.020 |
Why?
|
| Chemokine CXCL9 | 1 | 2011 | 8 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1991 | 35 | 0.020 |
Why?
|
| Floxuridine | 1 | 2011 | 20 | 0.020 |
Why?
|
| Oncogene Proteins v-myb | 1 | 1991 | 2 | 0.020 |
Why?
|
| Collagen Type III | 1 | 2011 | 21 | 0.020 |
Why?
|
| Veins | 1 | 2011 | 68 | 0.020 |
Why?
|
| Thymidine Kinase | 1 | 1991 | 18 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 1991 | 40 | 0.020 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2011 | 34 | 0.020 |
Why?
|
| Bleomycin | 1 | 2011 | 67 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 284 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 1990 | 20 | 0.020 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2011 | 76 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 219 | 0.020 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2010 | 13 | 0.020 |
Why?
|
| RNA | 1 | 1991 | 171 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 337 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 35 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1990 | 358 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2011 | 175 | 0.020 |
Why?
|
| Choriocarcinoma | 2 | 2003 | 7 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1046 | 0.020 |
Why?
|
| Pneumonia | 1 | 2011 | 110 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2010 | 45 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2010 | 58 | 0.020 |
Why?
|
| Leukocyte Rolling | 1 | 2009 | 2 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1990 | 114 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2009 | 27 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2010 | 114 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2009 | 59 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 2010 | 74 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1991 | 270 | 0.020 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2009 | 31 | 0.020 |
Why?
|
| Brain | 1 | 2020 | 2176 | 0.020 |
Why?
|
| Microcirculation | 1 | 2009 | 77 | 0.020 |
Why?
|
| Acetylation | 1 | 2009 | 94 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2009 | 108 | 0.020 |
Why?
|
| E-Box Elements | 1 | 2009 | 3 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2009 | 11 | 0.020 |
Why?
|
| Calgranulin A | 1 | 2009 | 5 | 0.020 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2009 | 15 | 0.020 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2009 | 22 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1991 | 368 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2009 | 66 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 33 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 499 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2009 | 133 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2009 | 149 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2009 | 134 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 189 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 49 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 196 | 0.020 |
Why?
|
| Spermidine | 1 | 1988 | 21 | 0.020 |
Why?
|
| Histones | 1 | 2009 | 111 | 0.020 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2009 | 44 | 0.020 |
Why?
|
| Rituximab | 1 | 2009 | 61 | 0.020 |
Why?
|
| Base Pairing | 1 | 2008 | 15 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2009 | 92 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2008 | 51 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 2083 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 1999 | 251 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2009 | 396 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2008 | 8 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2008 | 25 | 0.020 |
Why?
|
| Colitis | 1 | 2009 | 156 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 272 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 132 | 0.020 |
Why?
|
| DNA Footprinting | 2 | 1998 | 4 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2008 | 47 | 0.020 |
Why?
|
| Middle Aged | 3 | 2018 | 21147 | 0.020 |
Why?
|
| Harvey murine sarcoma virus | 1 | 1987 | 2 | 0.020 |
Why?
|
| Adult | 3 | 2018 | 21403 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2007 | 95 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2007 | 40 | 0.020 |
Why?
|
| Phylogeny | 1 | 2008 | 197 | 0.020 |
Why?
|
| Aorta | 1 | 2009 | 316 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2007 | 61 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2013 | 1451 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 2 | 1997 | 61 | 0.020 |
Why?
|
| Nuclear Localization Signals | 1 | 2006 | 5 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2009 | 382 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2009 | 269 | 0.020 |
Why?
|
| Exons | 1 | 2006 | 122 | 0.020 |
Why?
|
| Laminin | 1 | 2006 | 62 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 511 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2009 | 706 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2006 | 103 | 0.020 |
Why?
|
| Endocytosis | 1 | 2006 | 113 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2007 | 163 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2005 | 32 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2006 | 304 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2005 | 98 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 2455 | 0.020 |
Why?
|
| Computational Biology | 1 | 2006 | 190 | 0.020 |
Why?
|
| Myristic Acid | 1 | 2004 | 6 | 0.020 |
Why?
|
| Age Factors | 1 | 2009 | 1864 | 0.010 |
Why?
|
| Antibodies | 1 | 2005 | 241 | 0.010 |
Why?
|
| Bovine papillomavirus 1 | 1 | 1983 | 3 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 56 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 1983 | 26 | 0.010 |
Why?
|
| Sirolimus | 1 | 2004 | 118 | 0.010 |
Why?
|
| Biomarkers | 1 | 2009 | 1593 | 0.010 |
Why?
|
| Gene Amplification | 1 | 1983 | 71 | 0.010 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2003 | 3 | 0.010 |
Why?
|
| RNA, Viral | 1 | 1983 | 93 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1983 | 114 | 0.010 |
Why?
|
| Trophoblasts | 1 | 2003 | 29 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2003 | 11 | 0.010 |
Why?
|
| Insulin Antagonists | 1 | 2002 | 2 | 0.010 |
Why?
|
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2002 | 15 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 82 | 0.010 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2002 | 26 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2003 | 222 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2002 | 100 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 2000 | 23 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2000 | 69 | 0.010 |
Why?
|
| Virus Replication | 1 | 2000 | 104 | 0.010 |
Why?
|
| Caspase 9 | 1 | 1999 | 31 | 0.010 |
Why?
|
| Macrophage-1 Antigen | 1 | 1999 | 10 | 0.010 |
Why?
|
| Physical Chromosome Mapping | 1 | 1999 | 8 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1999 | 73 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1999 | 85 | 0.010 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1999 | 15 | 0.010 |
Why?
|
| Caspases | 1 | 1999 | 194 | 0.010 |
Why?
|
| Risk Factors | 1 | 2009 | 5731 | 0.010 |
Why?
|
| GA-Binding Protein Transcription Factor | 1 | 1998 | 2 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 1999 | 79 | 0.010 |
Why?
|
| Cell Separation | 1 | 1999 | 132 | 0.010 |
Why?
|
| Receptors, CCR1 | 1 | 1998 | 1 | 0.010 |
Why?
|
| Receptors, CCR3 | 1 | 1998 | 1 | 0.010 |
Why?
|
| Receptors, CCR5 | 1 | 1998 | 7 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 1998 | 16 | 0.010 |
Why?
|
| Sheep | 1 | 1998 | 128 | 0.010 |
Why?
|
| Receptors, CXCR4 | 1 | 1998 | 48 | 0.010 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 1997 | 17 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1997 | 20 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1998 | 173 | 0.010 |
Why?
|
| Transcription Factor Pit-1 | 1 | 1996 | 1 | 0.010 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 1996 | 14 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1996 | 29 | 0.010 |
Why?
|
| Prolactin | 1 | 1996 | 61 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 1999 | 245 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1997 | 146 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 4848 | 0.010 |
Why?
|
| Protein Prenylation | 1 | 1995 | 7 | 0.010 |
Why?
|
| Guanosine Diphosphate | 1 | 1995 | 12 | 0.010 |
Why?
|
| Phorbol Esters | 1 | 1995 | 37 | 0.010 |
Why?
|
| rap GTP-Binding Proteins | 1 | 1995 | 11 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1995 | 420 | 0.010 |
Why?
|
| Calcium | 1 | 1998 | 929 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1995 | 765 | 0.010 |
Why?
|
| Child | 1 | 2000 | 6405 | 0.010 |
Why?
|
| Aged | 1 | 2005 | 14862 | 0.010 |
Why?
|
| Adolescent | 1 | 2000 | 8912 | 0.000 |
Why?
|